ChartRow logo
Data provided bySource: Twelve Data
PeersMRKGILDJNJNVSPFEBMY
Share this page

AMGN financial statements

The full income statement, balance sheet, and cash-flow statement for Amgen Inc. (AMGN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +7.6%10Y CAGR +5.4%YoY +8.5%
$38.9B TTM$10.4B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

5Y CAGR +5.1%10Y CAGR +3.6%YoY +17.0%
$27.6B TTM$7.6B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR −0.1%10Y CAGR +0.7%YoY +46.9%
$12.6B TTM$3.7B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR +1.2%10Y CAGR +1.1%YoY +20.1%
$9.4B TTM$3.9B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +2.9%10Y CAGR +4.6%YoY +19.4%
$17.26 TTM$7.08 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y CAGR −1.0%10Y CAGR +0.2%YoY −9.5%
$12B TTM$4.2B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR +25.0%10Y CAGR +12.1%YoY +34.6%
$2.5B TTM$587M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR −3.9%10Y CAGR −1.2%YoY −14.0%
$9.6B TTM$3.7B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y −8.1%10Y −29.2%YoY +0.7%
544M TTM546M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR +8.0%10Y CAGR +11.7%YoY +5.9%
$10.08 TTM$2.52 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Every AMGN chart on Trends →

Shares outstanding (point-in-time)

2024-09 537.5M2024-12 537.2M2025-03 537.7M2025-06 538.4M2025-09 538.5M2025-12 539.1M2026-03 539.7M2026-06 540.6M2026-09 540.9M+0.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue36.8B+10.0%33.4B+18.6%28.2B+7.1%26.3B+1.3%26.0B+2.2%
24.7B+20.2%20.6B+4.2%19.7B-0.9%19.9B+2.0%19.5B+1.3%
Cost of revenue12.0B-6.4%12.9B+52.1%8.45B+31.9%6.41B-0.7%6.45B+4.8%
Research & development7.27B+21.9%5.96B+24.7%4.78B+7.9%4.43B-8.0%4.82B+14.5%
Selling, general & administrative7.05B-0.6%7.10B+14.8%6.18B+14.1%5.41B+0.9%5.37B-6.3%
Restructuring
——267M——
Amortization of intangibles4.30B-10.4%4.80B+50.0%3.20B+23.1%2.60B+0.0%2.60B-7.1%
Operating income9.08B+25.1%7.26B-8.1%7.90B-17.4%9.57B+25.2%7.64B-16.4%
Interest expense2.75B-12.7%3.15B+9.7%2.88B+104.5%1.41B+17.5%1.20B-5.2%
Interest & investment income408M-20.0%510M-57.5%1.20B+844.9%127M+1054.5%11.0M
Other non-operating income2.65B+423.9%506M-82.1%2.83B+448.0%-814M-414.3%259M+1.2%
Equity-method income—10.0M+190.9%-11.0M+98.8%-891M-2600.0%-33.0M+49.2%
Gain (loss) on equity securities109M+619.0%-21.0M-121.4%98.0M+159.4%-165M-202.5%161M-7.5%
Pre-tax income8.98B+94.7%4.61B-41.3%7.86B+6.9%7.35B+9.6%6.70B-17.6%
Income tax1.26B+143.7%519M-54.4%1.14B+43.3%794M-1.7%808M-7.0%
7.71B+88.5%4.09B-39.1%6.72B+2.5%6.55B+11.2%5.89B-18.9%
Net income to common7.71B+88.5%4.09B-39.1%6.72B+2.5%6.55B+11.2%5.89B-18.9%
$14.23+88.2%$7.56-39.5%$12.49+3.1%$12.11+17.8%$10.28-16.5%
EPS (basic)$14.33+88.1%$7.62-39.3%$12.56+3.1%$12.18+17.8%$10.34-16.6%
Weighted-avg shares (basic)538M+0.2%537M+0.4%535M-0.6%538M-5.6%570M-2.7%
Weighted-avg shares (diluted)542M+0.2%541M+0.6%538M-0.6%541M-5.6%573M-2.9%
Dividends per share$9.66+5.8%$9.13+5.7%$8.64+8.7%$7.95+10.1%$7.22+10.1%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
29.1B+0.1%29.0B-4.3%30.3B+36.7%22.2B+14.4%19.4B-8.3%
Cash & equivalents9.13B-23.8%12.0B+9.4%10.9B+43.5%7.63B-4.5%7.99B+27.5%
Accounts receivable9.57B+41.1%6.78B-6.7%7.27B+30.6%5.56B+13.6%4.89B+8.2%
Inventory6.22B-11.0%7.00B-26.5%9.52B+93.1%4.93B+20.7%4.09B+5.0%
Other current assets4.13B+26.1%3.28B+25.9%2.60B+9.0%2.39B+0.9%2.37B+13.9%
90.6B-1.4%91.8B-5.5%97.2B+49.2%65.1B+6.5%61.2B-2.8%
Property, plant & equipment7.91B+20.9%6.54B+10.1%5.94B+9.5%5.43B+4.7%5.18B+6.0%
Operating lease right-of-use602M+8.1%557M-14.4%651M+12.4%579M+2.3%566M+38.7%
Goodwill18.7B+0.2%18.6B+0.0%18.6B+20.0%15.5B+4.3%14.9B+1.4%
Intangible assets22.3B-19.6%27.7B-15.1%32.6B+103.0%16.1B+5.9%15.2B-8.5%
Other non-current assets12.7B+27.5%9.93B+3.3%9.61B+62.9%5.90B-9.6%6.52B+15.7%
25.5B+10.3%23.1B+25.6%18.4B+17.2%15.7B+28.8%12.2B+4.6%
Accounts payable2.37B+24.1%1.91B+20.0%1.59B+1.1%1.57B+15.1%1.37B-3.9%
Accrued liabilities18.5B+5.0%17.6B+14.9%15.4B+22.6%12.5B+16.7%10.7B+5.8%
Short-term & current debt4.60B+29.5%3.55B+146.0%1.44B-9.3%1.59B+1728.7%87.0M-4.4%
Current lease liability135M+26.2%107M-10.1%119M-23.7%156M+7.6%145M-5.2%
Long-term debt50.0B-11.6%56.5B-10.5%63.2B+69.1%37.4B+12.4%33.2B+1.0%
Non-current lease liability696M+3.4%673M-2.6%691M+28.2%539M+2.7%525M+71.6%
Operating lease liability (total)831M+6.5%780M-3.7%810M+16.5%695M+3.7%670M+46.0%
Deferred tax liabilities1.37B-15.5%1.62B-31.4%2.35B+21300.0%11.0M—
Other non-current liabilities2.38B+1.2%2.35B+1.0%2.33B-12.3%2.65B+7.5%2.46B+21.8%
8.66B+47.3%5.88B-5.7%6.23B+70.2%3.66B-45.4%6.70B-28.8%
Retained earnings-25.1B+9.0%-27.6B-3.9%-26.5B+7.2%-28.6B-16.3%-24.6B-14.9%
Accumulated other comprehensive income-258M-290.9%-66.0M+77.2%-289M-25.1%-231M+71.0%-796M+19.2%
Total equity incl. non-controlling8.66B+47.3%5.88B-5.7%6.23B+70.2%3.66B-45.4%6.70B-28.8%
Total liabilities & equity90.6B-1.4%91.8B-5.5%97.2B+49.2%65.1B+6.5%61.2B-2.8%
Common shares outstanding539M+0.4%537M+0.3%535M+0.3%534M-4.4%558M-3.5%
Shares outstanding (cover)539M+0.3%537M+0.2%536M+0.4%534M-4.1%557M-3.6%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
9.96B-13.3%11.5B+35.6%8.47B-12.9%9.72B+5.0%9.26B-11.8%
Depreciation & amortization5.17B-7.6%5.59B+37.4%4.07B+19.1%3.42B+0.6%3.40B-5.6%
Intangible amortization4.30B-10.4%4.80B+50.0%3.20B+23.1%2.60B+0.0%2.60B-7.1%
Share-based compensation494M-6.8%530M+23.0%431M+7.5%401M+17.6%341M+3.3%
Deferred income taxes-700M+43.5%-1.24B-1.9%-1.22B+4.7%-1.27B-193.8%-434M-19.6%
Change in receivables2.68B+706.8%-441M-143.4%1.01B+36.1%746M+73.9%429M+0.5%
Change in inventory-886M+65.0%-2.53B-415.7%-491M-166.2%742M+349.7%165M-23.3%
Change in payables428M+37.2%312M+177.6%-402M-361.0%154M+323.2%-69.0M-253.3%
-1.94B-85.8%-1.05B+96.0%-26.2B-333.6%-6.04B-924.6%733M+113.6%
Capital expenditure1.86B+69.5%1.10B-1.4%1.11B+18.8%936M+6.4%880M+44.7%
Free cash flow8.10B-22.1%10.4B+41.2%7.36B-16.2%8.79B+4.8%8.38B-15.2%
Acquisitions53.0M0.00-100.0%27.0B+603.0%3.84B+51.8%2.53B
Sales/maturities of investments0.000.00-100.0%550M-50.9%1.12B-87.3%8.83B+101.6%
Other investing activities32.0M+164.0%-50.0M+77.7%-224M-124.0%-100M-152.1%192M+156.0%
-10.9B-15.3%-9.41B-144.7%21.0B+621.4%-4.04B+51.2%-8.27B-69.9%
Long-term debt issued0.000.00-100.0%27.8B+301.5%6.92B+39.9%4.95B-44.5%
Long-term debt repaid5.00B+38.9%3.60B+147.6%1.45B0.00-100.0%4.15B-35.7%
Common stock issued0.000.000.000.000.00
Common stock repurchased0.00-100.0%200M0.00-100.0%6.36B+27.8%4.97B+42.7%
Dividends paid5.12B+6.0%4.83B+6.1%4.56B+8.6%4.20B+4.6%4.01B+6.9%
Other financing activities-52.0M+58.1%-124M-72.2%-72.0M+30.1%-103M-32.1%-78.0M+13.3%
Net change in cash-2.84B-376.4%1.03B-69.0%3.31B+1020.8%-360M-120.9%1.72B+652.4%
Interest paid2.90B-12.1%3.30B+37.5%2.40B+100.0%1.20B+0.0%1.20B+0.0%
Income taxes paid4.30B+48.3%2.90B-14.7%3.40B+41.7%2.40B+26.3%1.90B+35.7%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap176B+26.0%140B-9.2%154B+10.0%140B+11.6%126B-5.5%
P/E22.9×-33.2%34.2×+67.9%20.4×-0.6%20.5×-3.8%21.3×+16.4%
P/S4.8×+14.6%4.2×-27.1%5.7×+7.9%5.3×+10.1%4.8×-7.6%
P/B20.4×-14.5%23.8×+18.3%20.1×-47.5%38.4×+104.6%18.7×+32.7%
P/FCF21.8×+61.7%13.5×-18.1%16.4×+5.5%15.6×+3.9%15.0×+11.5%
Earnings yield4.4%+49.6%2.9%-40.5%4.9%+0.6%4.9%+4.0%4.7%-14.1%
FCF yield4.6%-38.2%7.4%+22.1%6.1%-5.2%6.4%-3.8%6.7%-10.3%
Dividend yield3.0%-15.7%3.5%+16.8%3.0%-0.9%3.0%-5.7%3.2%+12.5%
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025Mr. Bradway$24.7M$49.4M$8.5M$166.63$192.38
FY2024—$24.4M$12.7M$9.8M$128.51$149.66
FY2023—$22.6M$29.1M$7.7M$137.84$138.39
FY2022—$21.4M$41.7M$7.2M$121.48$136.26
FY2021—$21.7M$17M$7.4M$100.87$122.53
FY2020—$20.1M$14.7M$6.7M——

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: AMGN’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AMGN filings on SEC EDGAR → Not investment advice.